Pharmaceutical co-crystals are novel class of pharmaceutical substances, which possess an apparent probability of advancement of polished physical properties offering stable and patentable solid forms. These multi-component crystalline forms influence pertinent physicochemical parameters like solubility, dissolution rate, chemical stability, physical stability, etc. which in turn result in the materials with superior properties to those of the free drug. Co-crystallization is a process by which the molecular interactions can be altered to optimize the drug properties. Co-crystals comprise a multicomponent system of active pharmaceutical ingredient (API) with a stoichiometric amount of a pharmaceutically acceptable coformer incorporated in the crystal lattice. By manufacturing pharmaceutical co-crystals, the physicochemical properties of a drug can be improved thus multicomponent crystalline materials have received renewed interest in the current scenario due to the easy administration in the pharmaceutical industry. There is an immense amount of literature available on co-crystals. However, there is a lack of an exhaustive review on a selection of coformers and regulations on co-crystals. The review has made an attempt to bridge this gap. The review also describes the methods used to prepare co-crystals with their characterization. Brief description on the pharmaceutical applications of co-crystals has also been incorporated here. Efforts are made to include reported works on co-crystals, which further help to understand the concept of co-crystals in depth.
Nifedipine, a calcium channel blocker, is effective in managing cardiovascular conditions. However, its variable solubility in different solvent systems poses formulation challenges. Understanding its solubility behavior is crucial for optimizing drug delivery strategies and enhancing therapeutic outcomes. This study employs various techniques rooted in established solubility theories to explore nifedipine solubility across different solvents. Experimental techniques, complemented by computational modelling, including extended Hildebrand solubility approach, Hansen’s approach, and polynomial regression analysis are used. Experimental data on nifedipine solubility in various solvent blends are collected and analyzed to elucidate the underlying molecular interactions driving solubility. The study reveals that nifedipine exhibits complex solubility behavior influenced by factors such as solvent polarity (\({{\delta }_{{2p~~}}} = 3.90{\text{\;H}}\)), dispersion forces (\({{\delta }_{{2d}}} = 8.23{\text{\;H}}\)), and hydrogen bonding interactions (\({{\delta }_{{2a}}} = 6.65{\text{\;H}},{\text{\;}}{{\delta }_{{2b}}} = 0.93{\text{\;H}}),\) as found from four parameter approach. These results align with the chemical structure of nifedipine, offering insight into the drug ability to interact. Hydrogen bonding partial parameters provided a rational explanation for the solubility behavior of nifedipine, highlighting its role as a proton donor and Lewis acid. The technique of ideal solubility intersecting observed mole fraction solubility (10.62 H) proved valuable in predicting nifedipine solubility, particularly when closely aligned with peak solubility (10.13 H). By examining the total solubility parameter values obtained from different methods, it can be concluded that the best solvents for nifedipine fall within \({{\delta }_{1}}\) values ranging from 10 to 13 H. These findings contribute to the understanding of nifedipine solubility and provide insights into the design of effective drug delivery systems.
In this work, we are the first to identify and report pharmaceutically effective cocrystals of the poorly soluble drug Modafinil (MOD) using a crystal engineering approach. A multi-component system of MOD with nicotinic acid (NIC) as the coformer at a 1:1 molar ratio was prepared to simultaneously improve the solubility, dissolution and bioavailability by applying a liquid assistant grinding technique. Nicotinic acid as a potential coformer for cocrystal preparation was predicted using a novel approach of the Hansen Solubility Parameter (HSP) group contribution method. Various evaluation parameters pertaining to confirm cocrystal formation, such as Fourier transformer infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and field emission scanning electron microscopy (FESEM) were carried out. Further effects of precipitation inhibitor Hydroxypropyl methyl cellulose (HPMC) on in-vivo bioavailability enhancement were also studied. MOD-NIC cocrystals formation was confirmed by integrating the results of instrumental techniques. Aqueous solubility and in-vivo pharmacokinetic study proved 5.96 and 1.88 times higher bioavailability, respectively, in the case of prepared cocrystals compared to MOD alone, whereas bioavailability further increased by 2.72 times when these cocrystals were administered in the presence of precipitation inhibitor. Hence, solid state manipulation was successful for preparing modafinil cocrystals as a potential method for illustrating several properties. The concept of cocrystals coupled with precipitation inhibitors significantly enhanced the bioavailability of modafinil.
1 June 2025 in Russian Journal of Physical Chemistry B
Solubility parameters have long been utilized in the pharmaceutical industry though their application extends to other industries as well. Therefore, it has become a pivotal area in the research. This communication is a review of the applications of solubility parameters in pharmaceutical applications. In addition, A thorough description of the experimental and computational approaches—from conventional to modern—used to ascertain solubility parameters is also provided. Solubility parameters are primarily used to help choose suitable organic solvents or solvent blends, coformers for cocrystals, excipients, polymers, formulations containing lipids, solid dispersions, and drug delivery systems involving nanoparticles or microparticles. Interestingly, partial solubility parameters are thought to be very helpful for developing a drug delivery system for weakly soluble compounds, especially in the early phases of development when resources and compound obtainability are limited. Although the experimental find outs of solubility parameters can be time-consuming, it offers significant value, as the resulting data contribute to the ongoing enhancement of computational predictions. These advancements ensure that solubility parameters will continue to be an essential tool for scientists in identifying effective drug formulations in the future.
18 November 2024 in Research Journal of Pharmacy and Technology
Solutions of drugs may behave as ideal solutions, real solutions, or irregular solutions. It is necessary to understand the behaviour of these solutions before attempting to handle them. Various theories/models are reported in the literature to explain their behaviour. The importance of models in predicting the solubility of aripiprazole is demonstrated using its solubility in dioxane-water blends. The method utilizes theoretical and semiempirical approaches to predict solubility. The experimental solubility data for aripiprazole are validated using both ideal and nonideal solutions, focusing on the Scatchard-Hildebrand equation for regular solutions. Furthermore, the Extended Hildebrand Solubility approach is employed to identify the most suitable equation that yields calculated solubility data in agreement with experimental results. Interestingly, a method that directly correlates the solubility parameter of solvent combinations with the logarithm of the mole fraction solubility produces findings comparable to those obtained with the Extended Hildebrand Solubility approach. The results imply that aripiprazole solutions behave as irregular solutions. The solubility profile of aripiprazole may be precisely determined using a quartic equation developed based on regression of activity coefficient versus solubility parameter of the solvent blends. This method saves time and money compared to experimental methods.